Diabetes mellitus in people living with HIV/AIDS: prevalence and associated risk factors

References

• Akl, L. D., Valadares, A. L. R., Moraes, M. J., Pinto-Neto, A. M., Lagrutta, B., & Costa-Paiva, L. (2017). Metabolic syndrome in HIV-infected middle-aged women on antiretroviral therapy: Prevalence and associated factors. The Brazilian Journal of Infectious Diseases, 21(3), 263–269. doi: 10.1016/j.bjid.2017.02.003
   PubMed Web of Science ®Google Scholar
• Alizon, S., & Magnus, C. (2012). Modelling the course of an HIV infection: Insights from ecology and evolution. Viruses, 4(10), 1984–2013. doi: 10.3390/v4101984
   PubMed Web of Science ®Google Scholar
• American Diabetes Association (ADA). (2017). Classification and diagnosis of diabetes. Diabetes Care, 40(1), S11–S24. doi: 10.2337/dc17-S005
   PubMedGoogle Scholar
• Anwara, O., Patrick, M., Edeogu, C., Kelechi, O., Moses, A., & Oka, G. (2015). The prevalence of diabetes mellitus in human immunodeficiency virus seropositive subject’s co-infected with mycobacterium tuberculosis. Journal of AIDS and HIV Research, 7(8), 109–116. doi: 10.5897/JAHR2015.0310
   Google Scholar
• Balderson, B. H., Grothaus, L., Harrisson, R. G., Mccoy, K., Mahoney, C., & Catz, S. (2013). Chronic illness burden and quality of life in an aging HIV population. AIDS Care, 25(4), 451–458. doi: 10.1080/09540121.2012.712669
   PubMed Web of Science ®Google Scholar
• Cahn, P., Rolón, M. J., Figueroa, M. I., Gun, A., Patterson, P., & Sued, O. (2017). Dolutegravir-lamivudine as initial therapy in HIV-1 infected, ARV-naive patients, 48-week results of the PADDLE (pilot antiretroviral design with dolutegravir lamivudine) study. Journal of the International AIDS Society, 20(1), 21678. doi: 10.7448/IAS.20.01.21678
   PubMed Web of Science ®Google Scholar
• Capeau, J., Bouteloup, V., Katlama, C., Bastard, J. P., Guiyedi, V., Salmon-Ceron, D., … Chêne, G. (2012). Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antirretroviral treatment. AIDS, 26(3), 303–314. doi: 10.1097/QAD.0b013e32834e8776
   PubMed Web of Science ®Google Scholar
• Cheng, W., Wu, Y., Dou, Z., Ma, Y., Sun, L., Li, Z., … Zhang, F. (2014). The prevalence and relevant factors of hyperglycemia in AIDS patients receiving antiretroviral therapy in a single center. Zhonghua nei ke za zhi, 53(6), 446–449.
   PubMedGoogle Scholar
• Chu, C., Pollock, L. C., & Selwyn, P. A. (2017). HIV-associated complications: A systems-based approach. American Family Physician, 96(3), 161–169.
   PubMed Web of Science ®Google Scholar
• Coleman, C. L. (2017). Health related quality of life and depressive symptoms among seropositive African Americans. Applied Nursing Research, 33, 138–141. doi: 10.1016/j.apnr.2016.11.007
   PubMed Web of Science ®Google Scholar
• Dimala, C. A., Atashili, J., Mbuagbaw, J. C., Wilfred, A., & Monekosso, G. L. (2016). A comparison of the diabetes risk score in HIV/AIDS patients on highly active antiretroviral therapy (HAART) and HAART-naïve patients at the Limbe Regional Hospital, Cameroon. PLoS one, 11(5), e0155560. doi: 10.1371/journal.pone.0155560
   PubMed Web of Science ®Google Scholar
• Divala, O. H., Amberbir, A., Ismail, Z., Beyene, T., Garone, D., Pfaff, C., … Van Oosterhout, J. J. (2016). The burden of hypertension, diabetes mellitus, and cardiovascular risk factors among adult Malawians in HIV care: Consequences for integrated services. BMC Public Health, 16(1), 1243. doi: 10.1186/s12889-016-3916-x
   PubMed Web of Science ®Google Scholar
• Duncan, A. D., Goff, L. M., & Peters, B. S. (2018). Type 2 diabetes prevalence and its risk factors in HIV: A cross-sectional study. PLoS one, 13(3), e0194199. doi: 10.1371/journal.pone.0194199
   PubMed Web of Science ®Google Scholar
• Galli, L., Salpietro, S., Pellicciotta, G., Galliani, A., Piatti, P., Hasson, H., … Castagna, A. (2012). Risk of type 2 diabetes among HIV-infected and healthy subjects in Italy. European Journal of Epidemiology, 27(8), 657–665. doi: 10.1007/s10654-012-9707-5
   PubMed Web of Science ®Google Scholar
• Hernandez-Romieu, A. C., Garg, S., Rosenberg, E. S., Thompson-Paul, A. M., & Skarbinski, J. (2017). Is diabetes prevalence higher among HIV-infected individuals compared with the general population? Evidence from MMP and NHANES 2009–2010. BMJ Open Diabetes Research & Care, 5(1), e000304. doi: 10.1136/bmjdrc-2016-000304
   PubMed Web of Science ®Google Scholar
• Hernández-Vázquez, L. R., Martinez, J. H., Rivera-Anaya, C., Laboy, J., Miranda, S., Mancilla, P., … Vélez, S. (2015). Prevalence of diabetes mellitus in human immunodeficency virus positive patients in Puerto Rico - San Juan City hospital experience. Boletín de la Asociación Médica de Puerto Rico, 107(3), 5–8.
   PubMedGoogle Scholar
• Karamchand, S., Leisegang, R., Schomaker, M., Maartens, G., Walters, L., Hislop, M., … Cohen, K. (2016). Risk factors for incident diabetes in a cohort taking first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy. Medicine, 95(9), e2844. doi: 10.1097/MD.0000000000002844
   PubMed Web of Science ®Google Scholar
• Klein, D. B., Leyden, W. A., Xu, L., Chao, C. R., Horberg, M. A., Towner, W. J., … Silverberg, M. J. (2015). Declining relative risk for myocardial infarction among HIV-positive compared with HIV-negative individuals with access to care. Clinical Infectious Diseases, 60(8), 1278–1280. doi: 10.1093/cid/civ014
   PubMed Web of Science ®Google Scholar
• Kumar, S., Mohanraj, R., Rao, D., Murray, K. R., & Manhart, L. E. (2015). Positive coping strategies and HIV-related stigma in south India. AIDS Patient Care and STDs, 29(3), 157–163. doi: 10.1089/apc.2014.0182
   PubMed Web of Science ®Google Scholar
• Lichtenstein, K. A., Hart, R. L., Wood, K. C., Bozzette, S., Buchacz, K., Brooks, J. T., …  HIV Outpatient Study Investigators (2015). Statin use is associated with incident diabetes mellitus among patients in the HIV outpatient study. Journal of Acquired Immune Deficiency Syndromes, 69(3), 306–311. doi: 10.1097/QAI.0000000000000581
   PubMed Web of Science ®Google Scholar
• Malachias, M. V. B., Gomes, M. A. M., Nobre, F., Alessi, A., Feitosa, A. D., & Coelho, E. B. (2016). 7th Brazilian Guideline of arterial hypertension: Chapter 2 - Diagnosis and Classification. Arquivos Brasileiros de Cardiologia, 107(3), 7–13. doi: 10.5935/abc.20160152
   PubMed Web of Science ®Google Scholar
• McMahon, C. N., Petoumenos, K., Hesse, K., Carr, A., Cooper, D. A., & Samaras, K. (2018). High rates of incident diabetes and prediabetes are evident in men with treated HIV followed for 11 years. AIDS, 32(4), 451–459. doi: 10.1097/QAD.0000000000001709
   PubMed Web of Science ®Google Scholar
• Ministry of Health of Brazil. (2017). Epidemiological Bulletin - AIDS and STD. Year V, n° 01. Brazil: Ministry of Health.
   Google Scholar
• Muyanja, D., Muzoora, C., Muyingo, A., Muyindike, W., & Siedner, M. J. (2016). High prevalence of metabolic syndrome and cardiovascular disease risk among people with HIV on stable ART in Southwestern Uganda. AIDS Patient Care and STDs, 30(1), 4–10. doi: 10.1089/apc.2015.0213
   PubMed Web of Science ®Google Scholar
• Petoumenos, K., Worm, S. W., Fontas, E., Weber, R., De Wit, S., Bruyand, M., … Law, M. G. (2012). Predicting the short-term risk of diabetes in HIV-positive patients: The data collection on adverse events of anti-HIV drugs (D:A:D) study. Journal of the International AIDS Society, 15(2), 17426. doi: 10.7448/IAS.15.2.17426
   PubMedGoogle Scholar
• Riyaten, P., Salvadori, N., Traisathit, P., Ngo-Giang-Huong, N., Cressey, T. R., Leenasirimakul, P., … Jourdain, G. (2015). New-onset diabetes and antiretroviral treatments in HIV-infected adults in Thailand. Journal of Acquired Immune Deficiency Syndromes, 69(4), 453–459. doi: 10.1097/QAI.0000000000000647
   PubMed Web of Science ®Google Scholar
• Rodger, A. J., Cambiano, V., Bruun, T., Vernazza, P., Collins, S., Van Lunzen, J., … Lundgren, J. (2016). Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA, 316(2), 171–181. doi: 10.1001/jama.2016.5148
   PubMed Web of Science ®Google Scholar
• Safren, S. A., Mayer, K. H., Ou, S. S., McCauley, M., Grinsztejn, B., Hosseinipour, M. C., … Cohen, M. S. (2015). Adherence to early antiretroviral therapy: Results from HPTN 052, a Phase III, multinational randomized trial of ART to prevent HIV-1 sexual transmission in serodiscordant couples. Journal of Acquired Immune Deficiency Syndromes, 69(2), 234–240. doi: 10.1097/QAI.0000000000000593
   PubMed Web of Science ®Google Scholar
• Shankalala, P., Jacobs, C., Bosomprah, S., Vinikoor, M., Katayamoyo, P., & Michelo, C. (2017). Risk factors for impaired fasting glucose or diabetes among HIV infected patients on ART in the Copperbelt Province of Zambia. Journal of Diabetes and Metabolic Disorders, 16, 29. doi: 10.1186/s40200-017-0310-x
   PubMed Web of Science ®Google Scholar
• Tshering, P., Lhazeen, K., Wangdi, S., & Tshering, N. (2016). Twenty-two years of HIV infection in Bhutan: Epidemiological profile. Journal of Virus Eradication, 2(4), 45–48.
   PubMedGoogle Scholar
• UNAIDS Joint United Nations Programme on HIV/AIDS. (2017). Ending aids - Progress towards the 90-90-90 targets. Geneva: UNAIDS.
   Google Scholar
• Willig, A. L., & Overton, E. T. (2016). Metabolic complications and glucose metabolism in HIV infection: A review of the evidence. Current HIV/AIDS Reports, 13(5), 289–296. doi: 10.1007/s11904-016-0330-z
   PubMed Web of Science ®Google Scholar
• Willig, A. L., Westfall, A. O., Overton, E. T., Mugavero, M. J., Burkholder, G. A., Kim, D., … Willig, J. H. (2015). Obesity is associated with race/sex disparities in diabetes and hypertension prevalence, but not cardiovascular disease, among HIV-infected adults. AIDS Research and Human Retroviruses, 31(9), 898–904. doi: 10.1089/AID.2015.0062
   PubMed Web of Science ®Google Scholar